Tectonic Therapeutic Inc/$TECX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tectonic Therapeutic Inc
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Ticker
$TECX
Sector
Primary listing
Employees
60
Headquarters
Website
TECX Metrics
BasicAdvanced
$555m
-
-$4.46
-
-
Price and volume
Market cap
$555m
52-week high
$36.03
52-week low
$14.39
Average daily volume
205k
Financial strength
Current ratio
18.513
Quick ratio
18.282
Long term debt to equity
1.39
Total debt to equity
2.011
Interest coverage (TTM)
-1,824.29%
Profitability
EBITDA (TTM)
-91.72
Effective tax rate (TTM)
-1.50%
Management effectiveness
Return on assets (TTM)
-20.72%
Return on equity (TTM)
-31.42%
Valuation
Price to book
2.4
Price to tangible book (TTM)
2.4
Price to free cash flow (TTM)
-8.388
Free cash flow yield (TTM)
-11.92%
Free cash flow per share (TTM)
-3.504
Growth
Earnings per share change (TTM)
-5.52%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs